NASDAQ:HUMA | Free Cash Flow | Humacyte, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-09-30 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$25.1M$175,000.00-$25.28M
2025-12-31-$26.12M$39,000.00-$26.16M
2025-03-31-$28.6M$228,000.00-$28.83M-73.66%
2024-12-31-$26.58M$63,000.00-$26.64M
2024-03-31-$27.35M$391,000.00-$27.74M
2023-12-31-$19.05M$150,000.00-$19.2M
2023-03-31-$18.64M$1.15M-$19.79M
2022-12-31-$18.96M$681,000.00-$19.64M
2022-03-31-$18.8M$22,000.00-$18.82M
2021-12-31-$21.45M$45,000.00-$21.49M-50.47%
2021-03-31-$14.54M$29,000.00-$14.57M
2020-12-31-$15.2M$13,000.00-$15.21M
2020-09-30-$18,049.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$105.04M$884,000.00-$105.93M
2024-12-31-$98.12M$1.57M-$99.69M
2023-12-31-$73.31M$2.28M-$75.59M
2022-12-31-$71.13M$1.05M-$72.18M
2021-12-31-$81.19M$220,000.00-$81.41M
2020-12-31-$55.57M$318,000.00-$55.89M